Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Hile Bio-Technology Co Total Current Liabilities Chart
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.
Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.
What does a Total Current Liabilities of ¥138.4 Mil mean?
Shanghai Hile Bio-Technology Co (SHSE:603718) has a Total Current Liabilities of ¥138.4 Mil as of Mar. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Shanghai Hile Bio-Technology Co and its competitors.
Is Shanghai Hile Bio-Technology Co's Total Current Liabilities too high?
Shanghai Hile Bio-Technology Co's current Total Current Liabilities is ¥138.4 Mil. Overall, Shanghai Hile Bio-Technology Co has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Hile Bio-Technology Co's Total Current Liabilities compare to VRTX and REGN?
Shanghai Hile Bio-Technology Co's Total Current Liabilities of ¥138.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Biotechnology company?
A good Total Current Liabilities depends on the Biotechnology industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Shanghai Hile Bio-Technology Co and its competitors. Shanghai Hile Bio-Technology Co's current Total Current Liabilities is ¥138.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Hile Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co (SHSE:603718) is currently considered Possible Value Trap. The stock's GF Value™ is ¥4.26, compared to a current price of ¥2.71 — trading 36.4% below its estimated fair value. The current Total Current Liabilities is ¥138.4 Mil. Shanghai Hile Bio-Technology Co's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Shanghai Hile Bio-Technology Co (SHSE:603718), the current Total Current Liabilities is ¥138.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Hile Bio-Technology Co (SHSE:603718) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co stock appears to be undervalued.
The current stock price of ¥2.71 is trading 36.4% below its estimated GF Value™ of ¥4.26.
GuruFocus considers Shanghai Hile Bio-Technology Co to be Possible Value Trap.
Key valuation signals for SHSE:603718:
Total Current Liabilities: ¥138.4 Mil
GF Value™: ¥4.26 vs. price of ¥2.71 (36.4% below fair value)
No single metric tells the full story. See the SHSE:603718 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Hile Bio-Technology Co Business Description
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
47GF Score
Get the complete analysis for SHSE:603718
Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603718 has been successfully added to your 
